Latest News about JNJ
Recent news which mentions JNJ
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
May 05, 2025
From Benzinga
From Benzinga
Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now
May 05, 2025
From Motley Fool
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
May 04, 2025
From Motley Fool
From Benzinga
From Benzinga
From TalkMarkets
From Benzinga
Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications
April 28, 2025
From Benzinga
From Benzinga
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
April 26, 2025
From Motley Fool
3 Dividend Kings That Have Raised Their Payouts in 2025
April 24, 2025
From Motley Fool
In the Wake of the Trump Tariff Crash: 2 Unparalleled Dividend Stocks to Buy at a Discount Right Now
April 24, 2025
From Motley Fool
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
April 23, 2025
From Benzinga
From Benzinga
From Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
April 22, 2025
From Benzinga
From Motley Fool
From $50 A Month To $1M Portfolio — Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline
April 19, 2025
From Benzinga
Stocks That Weathered Past Recessions: Expert Shares Picks That Withstood Every Downturn
April 19, 2025
From Benzinga
From Motley Fool
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
April 18, 2025
From Benzinga
Where Will Eli Lilly Be in 5 Years?
April 18, 2025
From Motley Fool
4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market
April 17, 2025
Tickers
JNJ
From Motley Fool
This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row
April 17, 2025
From Motley Fool
From Benzinga
Johnson & Johnson's Q1 Results, FY Guidance Highlight The 'Power Of The Pharma Portfolio'
April 16, 2025
Tickers
JNJ
From Benzinga